Document is current
Any future updates will be listed below
-
Authors
Yeo, Dannel https://orcid.org/0000-0002-6546-1209
Seyfi, Doruk
Bastian, Althea
Strauss, Heidi
Leach, Anna
Klemm, Vera
Pirrello, Anthony
Spring, Kevin
Saxena, Payal
Wahlroos, Sara
Sutherland, Sarah
Grimison, Peter
Park, Jin-soo
Sandroussi, Charbel
Rasko, John EJ
-
Funding
Funding for this research was provided by:
University of Sydney
- License Information
-
More Information
Article History
Received: 11 November 2024
Revised: 16 March 2025
Accepted: 19 March 2025
First Online: 10 April 2025
Declarations
:
: Ethics approval and consent was obtained from all participants (Sydney Local Health District Human Research Ethics Committee: X19-0321, X19-0490).
: Not applicable.
: JEJR reports advisory roles in The Gene Technology Technical Advisory Committee, Office of the Gene Technology Regulator, Australian Government; and Human Research Ethics Committee, Genea. JEJR also reports honoraria speaker fees or advisory roles for Cynata, Pfizer, Spark;Woke Pharmaceutical (shares); Kennerton Capital (non-executive director); AAVec Bio (co-founder); consultant role for Rarecyte (stocks in lieu).
